Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential
Authors
Keywords
-
Journal
Biomolecules
Volume 11, Issue 6, Pages 777
Publisher
MDPI AG
Online
2021-05-24
DOI
10.3390/biom11060777
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory Potential of GSK-3 Inhibitors
- (2021) Arindam Maity et al. CURRENT DRUG TARGETS
- Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism
- (2021) Alessio Basolo et al. SEMINARS IN CANCER BIOLOGY
- High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic review
- (2021) Sophie L. Gerritse et al. CANCER TREATMENT REVIEWS
- Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia
- (2020) Pyeonghwa Jeong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of IMR-23 an oxime derived from nitroimidazole as immunomodulatory molecule
- (2020) Esmeralda Sánchez-Pavón et al. Current Drug Delivery
- ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
- (2020) Miroslav Boudny et al. CANCER TREATMENT REVIEWS
- Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors
- (2020) Pankaj Wadhwa et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats
- (2020) Mark B. Plotnikov et al. HYPERTENSION RESEARCH
- Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer
- (2020) Giulio Evangelisti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis
- (2020) Liliya N. Kirpotina et al. Frontiers in Pharmacology
- The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
- (2020) Giuseppa Augello et al. Cells
- Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia
- (2020) Mark B. Plotnikov et al. Cells
- The indirubin derivative 6-bromoindirubin-3′-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference
- (2020) Anna Czapka et al. BIOCHEMICAL PHARMACOLOGY
- Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review
- (2020) Vaishnavi Sundar et al. GENE
- Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
- (2020) Masako Yumura et al. MOLECULES
- JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis
- (2020) Zhelong Nie et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
- (2020) Ting Guo et al. ChemMedChem
- The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
- (2020) Nicole Brighi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity
- (2020) Karima Alim et al. Expert Opinion on Drug Metabolism & Toxicology
- 6-Bromoindirubin-3′-oxime Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cells and Facilitates Bone Regeneration in a Mouse Periodontitis Model
- (2020) Song Shen et al. ACS Biomaterials-Science & Engineering
- The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
- (2020) Lee S. Simon et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy
- (2019) Noëmie Jean LeBlanc et al. MOLECULAR NEUROBIOLOGY
- Investigational multitargeted kinase inhibitors in development for head and neck neoplasms
- (2019) Ana Marija Sola et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
- (2019) Ilyas Sahin et al. CANCER BIOLOGY & THERAPY
- 22-Oxocholestane oximes as potential anti-inflammatory drug candidates
- (2019) Reyna Zeferino-Díaz et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Indirubin-3′-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain
- (2019) C. Sathiya Priya et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibitory effects of indirubin‐3′‐monoxime against human osteosarcoma
- (2019) Yi Zhang et al. IUBMB LIFE
- Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats
- (2019) Mark B. Plotnikov et al. MOLECULES
- 6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-aging Effects in Rodent Liver
- (2019) Donghao Guo et al. Frontiers in Pharmacology
- A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications
- (2019) L Crocetti et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Amidoximes and Oximes: Synthesis, Structure, and Their Key Role as NO Donors
- (2019) Tanya Sahyoun et al. MOLECULES
- Current approaches to enhancing oxime reactivator delivery into the brain
- (2019) Tereza Kobrlova et al. TOXICOLOGY
- A novel small molecule A2A adenosine receptor agonist, indirubin-3′-monoxime, alleviates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes
- (2019) Saynaz A. Choudhary et al. BIOCHEMICAL JOURNAL
- Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade
- (2019) Ting Yuan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3′-oxime (7BIO)
- (2019) Micaela R. Scobie et al. CHEMICO-BIOLOGICAL INTERACTIONS
- 6-Bromoindirubin-3′-Oxime Suppresses LPS-Induced Inflammation via Inhibition of the TLR4/NF-κB and TLR4/MAPK Signaling Pathways
- (2019) Chang Liu et al. INFLAMMATION
- Oleanolic acid oxime derivatives and their conjugates with aspirin modulate the NF-κB-mediated transcription in HepG2 hepatoma cells
- (2019) Violetta Krajka-Kuźniak et al. BIOORGANIC CHEMISTRY
- New ibuprofen derivatives as H2S and NO donors as safer anti-inflammatory agents
- (2019) Ghaneya S Hassan et al. Future Medicinal Chemistry
- BIO alleviates inflammation through inhibition of GSK-3β in a rat model of intracerebral hemorrhage
- (2019) Sha Zhao et al. JOURNAL OF NEUROSURGERY
- Aurora Kinase Inhibitors in Head and Neck Cancer
- (2018) Guangying Qi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study
- (2018) Dinesh S. Reddy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors
- (2018) Hany A.M. El-Sherief et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Oximes: Unrecognized Chameleons in General and Specialized Plant Metabolism
- (2018) Mette Sørensen et al. Molecular Plant
- A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro
- (2018) Maciej Masłyk et al. SAUDI PHARMACEUTICAL JOURNAL
- c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
- (2018) Maria Shvedova et al. Frontiers in Pharmacology
- Modified Ldl Particles Activate Inflammatory Pathways In Monocyte-Derived Macrophages: Transcriptome Analysis
- (2018) Alexander N. Orekhov et al. CURRENT PHARMACEUTICAL DESIGN
- Indirubin-3'-oxime suppresses human cholangiocarcinoma through cell-cycle arrest and apoptosis
- (2018) Ming-Yang Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Design, synthesis, and biological evaluation of novel thiazolyl substituted bis-pyrazole oxime derivatives with potent antitumor activities by selectively inducing apoptosis and ROS in cancer cells
- (2018) Biao Xiong et al. Medicinal Chemistry
- Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1
- (2018) Laura E. Kolsi et al. Scientific Reports
- Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase
- (2018) Andrew J. Franjesevic et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors
- (2018) Igor A. Schepetkin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Preliminary pharmacokinetic study of the anticancer 6BIO in mice using an UHPLC-MS/MS approach
- (2018) Job Tchoumtchoua et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity
- (2017) Qin Li et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule
- (2017) Xinlai Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells
- (2017) Xiaowei Zhang et al. MOLECULAR THERAPY
- Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
- (2017) Hyo Jeong Lee et al. Oncotarget
- Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
- (2017) Karyn Muzinga Ndolo et al. Immune Network
- How to Triage PAINS-Full Research
- (2016) Jayme L. Dahlin et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety
- (2016) Ling Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis, antibacterial and cytotoxic activities of new biflorin-based hydrazones and oximes
- (2016) Luciana G. da S. Souza et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening
- (2016) Myoung Eun Jung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Indirubin-3-Oxime Prevents H2O2-Induced Neuronal Apoptosis via Concurrently Inhibiting GSK3β and the ERK Pathway
- (2016) Jie Yu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Discovery of Chromeno[4,3-c]pyrazol-4(2H)-one Containing Carbonyl or Oxime Derivatives as Potential, Selective Inhibitors PI3Kα
- (2016) Liang Lu et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- ( E )-1,3-diphenyl-1 H -pyrazole derivatives containing O-benzyl oxime moiety as potential immunosuppressive agents: Design, synthesis, molecular docking and biological evaluation
- (2016) Xian-Hai Lv et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor
- (2016) Chaluveelaveedu Murleedharan Nisha et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Development and validation of a FIA/UV–vis method for p K a determination of oxime based acetylcholinesterase reactivators
- (2016) Karel Musil et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- 16α, 17α-epoxypregnenolone-20-oxime inhibits NO and IL-6 production in LPS-treated RAW264.7 cells
- (2016) HU-NAN SUN et al. Molecular Medicine Reports
- Indirubin-3′-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation
- (2016) Shu-gang Zhang et al. Neural Regeneration Research
- A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist
- (2016) M. Payrits et al. NEUROSCIENCE
- A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia–reperfusion injury in mice
- (2016) Dmitriy N. Atochin et al. NEUROSCIENCE LETTERS
- Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3
- (2015) Tsong-Long Hwang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9
- (2015) Lei Yan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3′-oxime (7BIO)
- (2015) Martina Broecker-Preuss et al. Cancer Cell International
- NS383 Selectively Inhibits Acid-Sensing Ion Channels Containing 1a and 3 Subunits to Reverse Inflammatory and Neuropathic Hyperalgesia in Rats
- (2015) Gordon Munro et al. CNS Neuroscience & Therapeutics
- Synthesis and evaluation of 3-ylideneoxindole acetamides as potent anticancer agents
- (2015) Chun-Tang Chiou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents
- (2015) Suckchang Hong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: Identification of novel proapoptotic agents
- (2015) Hong-En Qu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 5-Nitro-5′-hydroxy-indirubin-3′-oxime (AGM130), an indirubin-3′-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo
- (2015) Mee-Young Ahn et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
- (2015) Tina Blažević et al. Evidence-based Complementary and Alternative Medicine
- Indirubin derivatives: a patent review (2010 – present)
- (2015) Nicolas Gaboriaud-Kolar et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- An evaluation of indirubin analogues as phosphorylase kinase inhibitors
- (2015) Jaida Begum et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Oximes Induce Erection and Are Resistant to Oxidative Stress
- (2015) Bart Pauwels et al. Journal of Sexual Medicine
- The Small Molecule Indirubin-3'-Oxime Inhibits Protein Kinase R: Antiapoptotic and Antioxidant Effect in Rat Cardiac Myocytes
- (2015) Mary Priyanka Udumula et al. PHARMACOLOGY
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the Progress
- (2015) Gerald S. Falchook et al. SEMINARS IN ONCOLOGY
- Small-Molecule Inhibitor of Glycogen Synthase Kinase 3β 6-Bromoindirubin-3-oxime Inhibits Hematopoietic Regeneration in Stem Cell Recipient Mice
- (2015) Sylvie Shen et al. STEM CELLS AND DEVELOPMENT
- Screening-Based Translation of Public Research Encounters Painful Problems
- (2015) Jonathan B. Baell ACS Medicinal Chemistry Letters
- GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury
- (2014) Dae Won Park et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells
- (2014) Chris K.P. Mok et al. ANTIVIRAL RESEARCH
- 16α,17α-Epoxypregnenolone-20-oxime Prevent LPS-Induced NO Production and iNOS Expression in BV-2 Microglial Cells by Inhibiting JNK Phosphorylation
- (2014) Hu-Nan Sun et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- In vitro inflammatory/anti-inflammatory effects of nitrate esters of purines
- (2014) Loranne Maugé et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Indirubin Core Structure of Glycogen Synthase Kinase-3 Inhibitors as Novel Chemotype for Intervention with 5-Lipoxygenase
- (2014) Carlo Pergola et al. JOURNAL OF MEDICINAL CHEMISTRY
- NO‐Donating Oximes Relax Corpora Cavernosa Through Mechanisms Other than Those Involved in Arterial Relaxation
- (2014) Bart Pauwels et al. Journal of Sexual Medicine
- Vasorelaxation Induced by a New Naphthoquinone-Oxime is Mediated by NO-sGC-cGMP Pathway
- (2014) Bruna Dantas et al. MOLECULES
- Recent advances in synthesis and biological activity of triterpenic acylated oximes
- (2014) Barbara Bednarczyk-Cwynar et al. PHYTOCHEMISTRY REVIEWS
- 7,7′-Diazaindirubin—A small molecule inhibitor of casein kinase 2 in vitro and in cells
- (2013) Xinlai Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells
- (2013) Lucy Liu et al. CANCER BIOLOGY & THERAPY
- Indirubin-3′-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration
- (2013) Tina Blažević et al. CARDIOVASCULAR RESEARCH
- E/ZOxime Isomerism in PhC(NOH)CN
- (2013) D. Scott Bohle et al. CHEMISTRY-A EUROPEAN JOURNAL
- 1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities
- (2013) Gamal El-Din A.A. Abuo-Rahma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of glycogen synthase kinase-3β suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis
- (2013) Yong-Jin Kwon et al. JOINT BONE SPINE
- Participation of Nitric Oxide Pathway in the Relaxation Response Induced by E-cinnamaldehyde Oxime in Superior Mesenteric Artery Isolated From Rats
- (2013) Robson C. Veras et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Hemorrhagic Transformation: A Review of the Rate of Hemorrhage in the Major Clinical Trials of Acute Ischemic Stroke
- (2013) Eric S. Sussman et al. Frontiers in Neurology
- Structure-Activity Relationship Study of Androstene Steroids with Respect to Local Anti-inflammatory Activity
- (2012) Rohini Chaubal et al. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
- Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells
- (2012) Katerina A. Nicolaou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
- (2012) Limor Avrahami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specific and Cooperative Interactions between Oximes and PAMAM Dendrimers As Demonstrated by 1H NMR Study
- (2012) Seok Ki Choi et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling
- (2012) Sangkil Nam et al. Molecular Oncology
- Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells
- (2012) Sangkil Nam et al. Molecular Oncology
- Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFκB inhibitors
- (2012) Xufen Yu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- From Tyrian Purple to Kinase Modulators: Naturally Halogenated Indirubins and Synthetic Analogues
- (2012) Konstantina Vougogiannopoulou et al. PLANTA MEDICA
- Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
- (2012) Vassilios Myrianthopoulos et al. ACS Medicinal Chemistry Letters
- An indirubin derivative, E804, exhibits potent angiosuppressive activity
- (2011) Yuk-Kit Chan et al. BIOCHEMICAL PHARMACOLOGY
- Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells
- (2011) Jin-Kyung Kim et al. INFLAMMATION RESEARCH
- Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells
- (2010) Soo Jeong Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Biochemical Markers for Blood-Brain Barrier Dysfunction in Acute Ischemic Stroke Correlate with Evolution and Outcome
- (2010) Raf Brouns et al. EUROPEAN NEUROLOGY
- 5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity
- (2010) Soo-Jeong Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)
- (2010) Jeffrey T. Bagdanoff et al. JOURNAL OF MEDICINAL CHEMISTRY
- TRPA1 Modulation of Spontaneous and Mechanically Evoked Firing of Spinal Neurons in Uninjured, Osteoarthritic, and Inflamed Rats
- (2010) Steve McGaraughty et al. Molecular Pain
- Indirubin-3′-oxime inhibits inflammatory activation of rat brain microglia
- (2010) Hoon-Ji Jung et al. NEUROSCIENCE LETTERS
- Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: The role of water molecules examined
- (2010) Joseph M. Hayes et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo
- (2009) Kenneth R. LaMontagne et al. ANGIOGENESIS
- Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent Stenosis
- (2009) Hanna Hlawaty et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
- (2009) K. P. Hoeflich et al. CANCER RESEARCH
- Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation
- (2009) Veera Konda et al. Journal of Inflammation-London
- Design, evaluation and structure-Activity relationship studies of the AChE reactivators against organophosphorus pesticides
- (2009) Kamil Musilek et al. MEDICINAL RESEARCH REVIEWS
- Role of microglia in neuronal degeneration and regeneration
- (2009) Lisa Walter et al. Seminars in Immunopathology
- SIVELESTAT (SELECTIVE NEUTROPHIL ELASTASE INHIBITOR) IMPROVES THE MORTALITY RATE OF SEPSIS ASSOCIATED WITH BOTH ACUTE RESPIRATORY DISTRESS SYNDROME AND DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS
- (2009) Mineji Hayakawa et al. SHOCK
- Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
- (2009) Eléonore Beurel et al. TRENDS IN IMMUNOLOGY
- Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species
- (2009) E. F. Choo et al. XENOBIOTICA
- Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases
- (2008) Reddeppareddy Dandu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent and selective pyrazole-based inhibitors of B-Raf kinase
- (2008) Joshua D. Hansen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Leukotriene Signaling in Atherosclerosis and Ischemia
- (2008) Magnus Bäck CARDIOVASCULAR DRUGS AND THERAPY
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
- (2008) Christopher J. Yuskaitis et al. CELLULAR SIGNALLING
- Entry of Oximes into the Brain: A Review
- (2008) D. Lorke et al. CURRENT MEDICINAL CHEMISTRY
- Recent Developments in the Chemistry and in the Biological Applications of Amidoximes
- (2008) K. Fylaktakidou et al. CURRENT PHARMACEUTICAL DESIGN
- Wnt/β-catenin signaling controls development of the blood–brain barrier
- (2008) Stefan Liebner et al. JOURNAL OF CELL BIOLOGY
- Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin
- (2008) Kai Kessenbrock et al. JOURNAL OF CLINICAL INVESTIGATION
- Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period
- (2008) Konstantina Vougogiannopoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blood-brain barrier tight junction permeability and ischemic stroke
- (2008) Karin E. Sandoval et al. NEUROBIOLOGY OF DISEASE
- 2-Amino-5-thiazolyl motif: A novel scaffold for designing anti-inflammatory agents of diverse structures
- (2007) P.X. Franklin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started